The Kable

The Kable

Share this post

The Kable
The Kable
💉 Sanofi’s new CSR wing; Novartis stops cancer drug production; India seeks more data on a TB vaccine
Copy link
Facebook
Email
Notes
More
Friday Kable

💉 Sanofi’s new CSR wing; Novartis stops cancer drug production; India seeks more data on a TB vaccine

Gilead invests in Curebase; Biogen partners with MedRhythms

Vinod's avatar
Vinod
May 06, 2022
∙ Paid
1

Share this post

The Kable
The Kable
💉 Sanofi’s new CSR wing; Novartis stops cancer drug production; India seeks more data on a TB vaccine
Copy link
Facebook
Email
Notes
More
Share

So the WHO’s Covid mortality report is out, and the numbers are grim indeed. Which makes for a rather depressing Kable.

In today’s Kable: The J&J vax gets restricted; In India, obesity goes up, fertility down; Abu Dhabi trains doctors in using AI; Rwanda dreams big in vaccine production; Kenya gets a cholera outbreak; Sanofi is done with think tanks; No…

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More